Madrid engineering SME specializing in nano-surface manufacturing, medical device prototyping, and advanced imaging instrumentation for EU research consortia.
Inspiralia is a Madrid-based engineering and innovation SME specializing in advanced materials, surface technologies, and sensor/device development for industrial and biomedical applications. They design and prototype hardware — from point-of-care diagnostic devices and nano-photonic sensors to laser-textured mould surfaces and energy storage systems. Their recurring role across projects is translating lab-scale material science and physics concepts into manufacturable prototypes, bridging the gap between research teams and industrial production.
MouldTex (laser surface texturing of moulds), NewSkin (nano-enabled surfaces for industrial uptake), and HypoSens (nano-confined photonic systems) all centre on surface and nano-scale material manipulation.
ASTHMAPOC (point-of-care nitric oxide test), HypoSens (breast cancer detection sensor), and GAMMA-MRI (molecular imaging hardware) show repeated involvement in biomedical instrumentation.
NewSkin focuses on scaling nano-surface manufacturing to continuous production, while MouldTex targets friction-optimised mould production via laser texturing.
EnergyKeeper was their largest single grant (EUR 541K), indicating a substantial contribution to energy storage technology development.
SALTGAE (EUR 256K) involved algae-based treatment of saline wastewater, their second-largest funded project.
In their early H2020 period (2014–2017), Inspiralia worked across scattered domains — asthma diagnostics, wastewater treatment with algae, nano-photonics for cancer detection, and energy storage — suggesting a generalist engineering consultancy taking diverse technical challenges. From 2019 onward, their focus consolidated sharply around advanced surface technologies and manufacturing scale-up (MouldTex, NewSkin) and specialized imaging hardware (GAMMA-MRI). The trajectory shows a company narrowing from broad prototyping services toward two clearer niches: industrial nano-surface manufacturing and biomedical imaging instrumentation.
Inspiralia is consolidating around industrial nano-surface manufacturing and advanced medical imaging instrumentation, making them increasingly relevant for consortia in these two verticals.
Inspiralia operates almost exclusively as a participant (5 of 7 projects), with only one coordination and one third-party role, indicating they prefer to contribute technical expertise rather than manage consortia. With 85 unique partners across 20 countries from just 7 projects, they work in large, diverse consortia — typical of an SME that plugs into bigger teams as a specialized engineering contributor. This makes them a low-overhead partner: experienced in multi-country projects, unlikely to demand leadership, and accustomed to delivering specific technical work packages.
With 85 unique consortium partners across 20 countries from only 7 projects, Inspiralia has built a remarkably wide European network relative to their size. Their collaborations span from health research institutes to industrial manufacturing consortia, giving them cross-sector connections few SMEs of their scale can match.
Inspiralia occupies an unusual niche as an SME that can prototype across both industrial manufacturing and biomedical domains — most small firms specialize in one or the other. Their ability to work at the nano-scale for surface engineering while also building medical imaging and diagnostic devices makes them a versatile hardware development partner. For consortium builders, they offer the rare combination of hands-on engineering capability with the administrative agility of a small company experienced in EU project delivery.
